
# Title 21 - Food and Drugs
## Chapter I - Food and Drug Administration, Department of Health and Human Services
### Subchapter C - Drugs: General
#### PART 201 - LABELING
##### Subpart B - Labeling Requirements for Prescription Drugs and/or Insulin
###### ยง 201.57 Specific requirements on content and format of labeling for human prescription drug and biological products described in ยง 201.56(b)(1).
####### Warnings and precautions.

(10)A concise summary of the most clinically significant information required under paragraph (c)(6) of this section, with any appropriate subheadings, including information that would affect decisions about whether to prescribe a drug, recommendations for patient monitoring that are critical to safe use of the drug, and measures that can be taken to prevent or mitigate harm.
